Clustered regularly-interspaced short palindromic repeats also known as CRISPR is a gene editing tool. CRIPSR commercialization began in 2012 with emergence of number of startups and venture capitalists and showing their interest in infusing money into this technology. Academic and research firms are the main consumers of CRISPR gene editing tool followed by biotechnology companies. The number of patents for CRISPR is outclassing the patents of other gene editing tools such as ZFN and TALEN. The market is driven by high demand for plasmids, synthetic genes and high quality gene slicing techniques. Growing drug discovery, biotechnology and proteomics markets are also driving the market growth.
Browse Full Report Visit - http://www.acutemarketreports.com/report/global-crispr-market
The market is expected to grow at a CAGR of 43% from 2015 to 2021. This is driven by the fact that CRISPR is a new technology which is simple, more efficient and cost effective as compared to its peers. High adoption both in biotech and pharma industry along with high level of research is also responsible for high growth rate.
Companies profiled include
1. Thermo Fisher Scientific
2. Editas Medicine
3. Caribou Biosciences
4. CRISPR therapeutics
5. Intellia
6. Cellectis
7. Horizon discovery PLC
8. Sigma Aldrich
9. Precision biosciences
10. GenScript
11. Sangamo Biosciences Inc.
12. Lonza group limited
13. Integrated DNA technologies
14. New England Biolabs
15. Oregene Technologies
16. Transposgen Biopharmaceuticals
1. Thermo Fisher Scientific
2. Editas Medicine
3. Caribou Biosciences
4. CRISPR therapeutics
5. Intellia
6. Cellectis
7. Horizon discovery PLC
8. Sigma Aldrich
9. Precision biosciences
10. GenScript
11. Sangamo Biosciences Inc.
12. Lonza group limited
13. Integrated DNA technologies
14. New England Biolabs
15. Oregene Technologies
16. Transposgen Biopharmaceuticals
Browse All Reports of This Category - http://www.acutemarketreports.com/category/healthcare-market
1. Executive Summary
1.1. Estimation Methodology
1.1. Estimation Methodology
2. Market Overview
2.1. CRISPR- Introduction
2.2. Value chain analysis
2.3. Key buying criteria
2.4. Research and development
2.4.1. Patent analysis
2.5. CRISPR vs. Conventional gene editing tools
2.5.1. TALEN
2.5.2. ZFN
2.6. CRISPR: Novel initiatives
2.6.1. CRISPR/Cas9 technology
2.6.2. CRISPR as a gene editing tool to treat genetic disorders.
2.6.3. CRISP as a gene editing tool in drug development.
2.7. Strategic Recommendation and conclusion
2.1. CRISPR- Introduction
2.2. Value chain analysis
2.3. Key buying criteria
2.4. Research and development
2.4.1. Patent analysis
2.5. CRISPR vs. Conventional gene editing tools
2.5.1. TALEN
2.5.2. ZFN
2.6. CRISPR: Novel initiatives
2.6.1. CRISPR/Cas9 technology
2.6.2. CRISPR as a gene editing tool to treat genetic disorders.
2.6.3. CRISP as a gene editing tool in drug development.
2.7. Strategic Recommendation and conclusion
Send An Enquiry - http://www.acutemarketreports.com/request-free-sample/58819
3. Sector Analysis
3.1. Gene Editing Market
3.1. Gene Editing Market
4. Market Determinants
4.1. Drivers
4.1.1. Rise in drug discovery market
4.1.2. Demand for synthetic genes
4.1.3. High prevalence of genetic birth disorders
4.1.4. Age related genetic disorders
4.1.5. Rise in the healthcare research and development budgets
4.1.6. Venture capital
4.2. Restraints
4.2.1. Ethical issues related to misuse of CRISPR gene editing tool
4.2.2 Limited awareness
4.2.3. Limited presence in Emerging markets
4.3. Opportunities
4.3.1 CRISPR gene editing can open the market for gene surgery.
4.3.2. Emerging contract research market in Asia
4.4. Challenges
4.4.1. Patent infringement
4.4.2. Presence of alternative gene editing tools
4.1. Drivers
4.1.1. Rise in drug discovery market
4.1.2. Demand for synthetic genes
4.1.3. High prevalence of genetic birth disorders
4.1.4. Age related genetic disorders
4.1.5. Rise in the healthcare research and development budgets
4.1.6. Venture capital
4.2. Restraints
4.2.1. Ethical issues related to misuse of CRISPR gene editing tool
4.2.2 Limited awareness
4.2.3. Limited presence in Emerging markets
4.3. Opportunities
4.3.1 CRISPR gene editing can open the market for gene surgery.
4.3.2. Emerging contract research market in Asia
4.4. Challenges
4.4.1. Patent infringement
4.4.2. Presence of alternative gene editing tools
About - Acute Market Reports :
Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.
Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com
